Abstract
The concept of cognitive reserve (CR) was proposed to account for the discrepancy between levels of brain pathologic process or damage and clinical and cognitive function. We provide a detailed review of prospective longitudinal studies that have investigated the interaction between CR and Alzheimer disease (AD) biomarkers on clinical and cognitive outcomes among individuals with normal cognition at baseline. Current evidence is consistent with the view that higher levels of CR are associated with a delay in the onset of symptoms of mild cognitive impairment and that there may be multiple pathways by which CR exerts its protective effects.
Original language | English (US) |
---|---|
Pages (from-to) | 247-263 |
Number of pages | 17 |
Journal | Clinics in geriatric medicine |
Volume | 36 |
Issue number | 2 |
DOIs | |
State | Published - May 2020 |
Keywords
- Alzheimer disease
- Amyloid
- Atrophy
- Biomarkers
- Cognitive reserve
- Mild cognitive impairment
- Tau
ASJC Scopus subject areas
- Geriatrics and Gerontology